-And ␤-subunit composition of voltage-gated sodium channels investigated with -conotoxins and the recently discovered O §-conotoxin GVIIJ. J Neurophysiol 113: 2289 -2301, 2015. First published January 28, 2015 doi:10.1152/jn.01004.2014.-We investigated the identities of the isoforms of the ␣ (Na V 1)-and ␤ (Na V ␤)-subunits of voltage-gated sodium channels, including those responsible for action potentials in rodent sciatic nerves. To examine ␣-subunits, we used seven -conotoxins, which target site 1 of the channel. With the use of exogenously expressed channels, we show that two of the -conotoxins, -BuIIIB and -SxIIIA, are 50-fold more potent in blocking Na V 1.6 from mouse than that from rat. Furthermore, we observed that -BuIIIB and -SxIIIA are potent blockers of large, myelinated A-fiber compound action potentials (A-CAPs) [but not small, unmyelinated C-fiber CAPs (C-CAPs)] in the sciatic nerve of the mouse (unlike A-CAPs of the rat, previously shown to be insensitive to these toxins). To investigate ␤-subunits, we used two synthetic derivatives of the recently discovered O §-conotoxin GVIIJ that define site 8 of the channel, as previously characterized with cloned rat Na V 1-and Na V ␤-subunits expressed in Xenopus laevis oocytes, where it was shown that O §-GVIIJ is a potent inhibitor of several Na V 1-isoforms and that coexpression of Na V ␤2 or -␤4 (but not Na V ␤1 or -␤3) totally protects against block by O §-GVIIJ. We report here the effects of O §-GVIIJ on 1) sodium currents of mouse Na V 1.6 coexpressed with various combinations of Na V ␤-subunits in oocytes; 2) A-and C-CAPs of mouse and rat sciatic nerves; and 3) sodium currents of small and large neurons dissociated from rat dorsal root ganglia. Our overall results lead us to conclude that action potentials in A-fibers of the rodent sciatic nerve are mediated primarily by Na V 1.6 associated with Na V ␤2 or Na V ␤4.
and SS6), and the four domains are radially arranged, with each pore module contributing to a central, ion-conducting pore (Catterall 2014) . The ␤-subunit has some 200 AA residues and forms a single transmembrane-spanning segment that separates a large, extracellular domain from a smaller, intracellular C-terminal tail. The Na V ␤1-or Na V ␤3-subunit is noncovalently associated with the ␣-subunit, whereas the Na V ␤2-or Na V ␤4-subunit is covalently coupled to the ␣-subunit via a disulfide bond located on the extracellular aspect of the subunits (Calhoun and Isom 2014; Catterall 2012; Chen et al. 2012; Gilchrist et al. 2013; Yu et al. 2003) . A given neuron can have more than one single isoform of an ␣-subunit, and we are developing approaches to identify the functional contributions of each isoform through the use of conotoxins (Wilson et al. 2011a; Zhang et al. 2013b) .
Five families of conotoxins that target sodium channels have been identified thus far. Three families consist of peptides that are antagonists: -conotoxins, which are pore blockers, like TTX, and compete with TTX in binding to site 1 (Cestèle and Catterall 2000; Cruz et al. 1985; Zhang et al. 2009 Zhang et al. , 2010a ; O-conotoxins, which are gating modifiers that inhibit channel activation by interacting with site 4, the extracellular loop connecting S3 and S4 of DII Leipold et al. 2007 ); and O §-conotoxins, which bind to site 8, centered on a Cys residue between S5 and SS5 of DII [specifically, C910 in the case of rat Nav1.2 (rNa V 1.2)] but whose mechanism of block remains to be established (Gajewiak et al. 2014) . The other two conotoxin families consist of peptides that are VGSC agonists: ␦-conotoxins, which inhibit channel inactivation by binding to site 6 at the extracellular loop between S3 and S4 of DIV (Leipold et al. 2005) ; and -conotoxins, which promote channel activation but whose site of action on VGSCs remains to be established (Fiedler et al. 2008) . [For a recent review, see Stevens et al. (2011) .] These toxins possess varying degrees of Na V 1 specificities when examined with Xenopus laevis oocytes expressing cloned Na V 1s.
A compound action potential (CAP) consists of extracellularly recorded action potentials of a population of axons (or fibers). A-and C-CAPs are conducted by large, myelinated A-fibers and small, unmyelinated C-fibers, respectively; thus A-CAPs have faster conduction velocities than C-CAPs, and their waveforms are readily distinguishable by their latencies. We used a panel of -conotoxins to conclude that A-and C-CAPs in the rat sciatic nerve are mediated principally by Na V 1.6 and -1.7, respectively (Wilson et al. 2011a ). We also used -conotoxins to show that Na V 1.1, -1.6, and -1.7 could account for all of the TTX-sensitive voltage-gated sodium currents (I Na ) in cell bodies of acutely dissociated rat dorsal root ganglia (DRG) neurons; furthermore, the levels of functional Na V 1s in large neurons were Na V 1.7 Յ Na V 1.1 Յ Na V 1.6. In a class of small neurons, whose I Na was Ͼ50% sensitive to TTX, the levels were Na V 1.1 Յ Na V 1.6 Ͻ Ͻ Na V 1.7 (Zhang et al. 2013b) .
In contrast to Na V 1.6 from mouse (mNa V 1.6), much less has been reported concerning the functional and pharmacological properties of Na V 1.6 from rat (rNa V 1.6) since its initial description (Dietrich et al. 1998 ) until relatively recently (Gajewiak et al. 2014; He and Soderlund 2014; Tan et al. 2011; Tan and Soderlund 2011; Zhang et al. 2013a) . While comparing the abilities of various -conotoxins in blocking mNa V 1.6 expressed in oocytes and A-fibers of the rat sciatic nerve, we encountered an apparent discrepancy; that is, at the time of those experiments, only an mNa V 1.6 clone was available to us, and we noted that two of the -conopeptides tested, -SxIIIA and -BuIIIB, which were potent in blocking mNa V 1.6 expressed in oocytes, were unable to block A-CAPs in the rat sciatic nerve, unlike five other -conotoxins (-SmIIIA, -KIIIA, -SIIIA, -GIIIA, and -PIIIA) that readily blocked both rat A-CAPs and mNa V 1.6 (Wilson et al. 2011a) . [It might be noted that all five of the latter -conotoxins blocked mNa V 1.6 with submicromolar affinities (Wilson et al. 2011a) , and two of them, -SmIIIA and -PIIIA, were tested on rNa V 1.6, where they also blocked with submicromolar affinities (Zhang et al. 2013a ).] To reconcile the discrepancy, we suggested that the two -conotoxins, -SxIIIA and -BuIIIB, might be better able to block mNa V 1.6 than rNa V 1.6 (Wilson et al. 2011a) . With the use of our recently acquired clone of rNa V 1.6 (Zhang et al. 2013a ), we show here that this is indeed the case.
The affinities of -conotoxins for rNa V 1s can be affected by coexpression of Na V ␤-subunits (Zhang et al. 2013a ); thus we examined how the affinity of -SxIIIA for mNa V 1.6 is affected by coexpression with various combinations of rNa V ␤-subunits in oocytes (note, only rat clones of Na V ␤-subunits are presently available to us). Additionally, we tested -SxIIIA and -BuIIIB along with five other -conotoxins on A-and CCAPs of the mouse sciatic nerve to help identify likely Na V 1-isoforms responsible for the propagation of action potentials in mouse A-and C-fibers.
We also tested two closely related synthetic derivatives of the recently discovered O §-conotoxin GVIIJ, namely, O §-GVIIJ SSC and O §-GVIIJ SSG , where the subscripts refer, respectively, to cysteinylated and glutathionylated analogs that share the same peptide backbone (see MATERIALS AND METHODS) . O §-GVIIJ SSG was previously tested on oocytes expressing rNa V 1.1-rNa V 1.8, and it potently blocked all except Na V 1.5 and -1.8, which were blocked poorly and not at all, respectively (Gajewiak et al. 2014) . Except for a small (approximately threefold) difference in association rate constant (k on ) (Gajewiak et al. 2014) , both derivatives behave similarly in all functional tests performed thus far, including those reported here. For historical reasons, the early experiments were largely performed with O §-GVIIJ SSG , whereas more recent experiments involved O §-GVIIJ SSC , because its structure turned out to resemble more closely that of the native peptide (Gajewiak et al. 2014 ) (see MATERIALS AND METHODS). For brevity, the condensed term O §-GVIIJ SSC/G will be used when referring to both peptides.
The binding site of O §-GVIIJ SSC/G on the channel, site 8, is spatially distinct from those of site 1 (where -conotoxins bind) and site 4 (where O-conotoxins bind), insofar as electrophysiological tests reveal that neither the -conotoxin derivative -KIIIA[K7A] nor O-conotoxin MrVIB interferes with the block of rNa V 1.2 by O §-GVIIJ SSG (Gajewiak et al. 2014) .
A novel feature of O §-GVIIJ SSC/G , originally observed with O §-GVIIJ SSG , is that coexpression in oocytes of rNa V 1s with either Na V ␤2 or -␤4 protects the channel against block by the peptide (Gajewiak et al. 2014) . We demonstrate here that this is also true for mNa V 1.6; specifically, coexpression with Na V ␤2 or -␤4 (but not Na V ␤1 or -␤3) protects the channel against block by O §-GVIIJ SSC . We also show that unlike members of all other conopeptide families that target VGSCs, O §-GVIIJ SSC/G had no effect on A-and C-CAPs of rat and mouse sciatic nerves. Finally, we examined the ability of O §-GVIIJ SSG to block I Na , mediated by VGSCs endogenously expressed in acutely dissociated neurons of rat DRG, and observed that I Na of small, but not large, neurons could be blocked by the peptide.
MATERIALS AND METHODS
Toxins. -Conotoxins were synthesized as described previously (Wilson et al. 2011a) . TTX was obtained from Alomone Labs (Jerusalem, Israel). ␦-Conotoxin PVIA (␦-PVIA) was synthesized as described previously (Bulaj et al. 2001) .
The sequence of O §-GVIIJ is as follows: GWCGDOGATCG KLRLYCCSGFCDCYTKTCKDKSSÂ, where the seven Cys residues are in boldface, O represents hydroxyproline, the underlined C is Cys24, and the caret signifies a free carboxyl terminus. In the native peptide, Trp2 is bromoTrp, and Cys24 is disulfide bonded to a cysteine; i.e., Cys24 is S-cysteinylated (Gajewiak et al. 2014) . Two derivatives of the peptide, O §-GVIIJ SSC and O §-GVIIJ SSG , were synthesized as recently described (Gajewiak et al. 2014 ) and used in the present study. Trp2 in neither derivative was brominated, and the two derivatives differed from each other in that Cys24 was disulfide bonded either to cysteine (in O §-GVIIJ SSC ) or glutathione (in O §-GVIIJ SSG ). (Thus O §-GVIIJ SSC differs from the native peptide by only lacking bromination of Trp2.) The two peptides sharing the condensed term, O §-GVIIJ SSC/G , behaved similarly in blocking rNa V 1s expressed in oocytes (Gajewiak et al. 2014) . Their use in a given experiment of the present study was based, in part, on their availability at the time the experiment was performed.
Preparation and voltage clamp of X. laevis oocytes expressing cloned VGSCs. Clones for mNa v 1.6 (NM_011323), rNa V ␤1 (NM_017288), and rNa V ␤2 (NM_012877.1) were obtained from Alan Goldin (University of California, Irvine). The clone for rNa V 1.6 (NM_019266.2) was prepared as described previously (Zhang et al. 2013a) . Clones for rNa v ␤3 (NM_139097.3) and rNa v ␤4 (NM_ 001008880.1) were obtained from Lori Isom (University of Michigan, Ann Arbor). rNa v ␤1 and rNa v ␤2 DNA were linearized with NotI and transcribed with T7; rNa v ␤3 DNA was linearized with XbaI and transcribed with T7; and rNa v ␤4 DNA was linearized with BamHI and transcribed with T7.
Oocytes were harvested and prepared essentially as described previously (Cartier et al. 1996) . Briefly, freshly excised oocytes were treated with 2.5 mg/ml collagenase A (Roche Diagnostics, Indianapolis, IN) in OR-2 (82.5 mM NaCl, 2.0 mM KCl, 1.0 mM MgCl 2 , and 5.0 mM HEPES, pH 7.3) for 1-2 h on a rotary shaker at room temperature. Halfway through the collagenase treatment, the solution was exchanged with fresh collagenase solution. Following the enzyme treatment, oocytes were rinsed with OR-2 and incubated until used at 16°C in ND96 (96 mM NaCl, 2.0 mM KCl, 1.8 mM CaCl 2 , 1.0 mM MgCl 2 , and 5.0 mM HEPES, pH 7.3), supplemented with penicillin (100 U/ml) and streptomycin (0.1 mg/ml).
Injection of cRNA into oocytes was done as described previously (Wilson et al. 2011a; Zhang et al. 2013a ). Briefly, a given oocyte was injected with 30 -70 nl of 0.3 ng mNa V 1.6 or 117 ng rat cRNA in distilled water, without or with an equal weight of a rNa V ␤ cRNA. Oocytes were incubated at 16°C for 1-6 days in ND96, supplemented with the aforementioned antibiotics.
Oocytes were two-electrode voltage clamped with an OC-725C amplifier (Warner Instruments, Hamden, CT), using 3 M KCl-filled microelectrodes (Ͻ0.5 M⍀ resistance), essentially as described previously (Zhang et al. 2013a) . A holding potential of Ϫ80 mV was used, and I Na were induced every 20 s with a 50-ms depolarizing step to Ϫ10 mV. Current signals were filtered at 2 kHz, digitized at a sampling frequency of 10 kHz, and leak subtracted with a P/8 protocol using in-house software written in LabVIEW (National Instruments, Austin, TX). The recording chamber was a 4-mm diameter well (total volume of 30 l), sunk in Sylgard (Dow Corning, Midland, MI), a silicone elastomer. Toxins were dissolved in ND96, and oocytes were exposed to toxin by applying 3 l toxin solution (at 10ϫ the final concentration) to a static bath with a pipettor and manually stirring the bath for a few seconds by gently aspirating and expelling a few microliters of bath fluid several times with the pipettor. A static bath was used to conserve toxin, and toxins were washed out by continuous perfusion with ND96, initially at a rate of 1.5 ml/min for 20 s and then at a steady rate of 0.5 ml/min.
Oocyte data were analyzed as follows. Percentage block of peak I Na by toxin was determined by obtaining the average peak of greater than or equal to three control traces and the average peak of greater than or equal to three traces acquired at steady state in the presence of toxin and then dividing the latter by the former and multiplying by 100. Fitting of time-course data to a single exponential function was done with homemade software written with LabVIEW. The interaction of toxin with channel was assumed to be that of a simple bimolecular reaction whose kinetics are described by the equation, k obs ϭ k on [toxin] ϩ k off , where [toxin] is toxin concentration, k obs is the observed association rate constant, and k off is the disassociation rate constant. The time course of peak I Na was plotted before, during, and after exposure to toxin. The k on was determined as follows: the onset of block at a given [toxin] was fit to a single exponential function to yield the k obs , following which, k on was obtained from the linear-regression slope of a k obs vs.
[toxin] plot for at least three different [toxins] (where each concentration was tested on greater than or equal to three oocytes), as described previously (Zhang et al. 2013a ). The k off was determined by fitting the toxin-washout curve to a single-exponential function; however, when recovery from block was very slow (Ͻ50% recovery after 20 min; i.e., k off Ͻ 0.035/min), k off was estimated from the level of recovery observed after 20 min of washing and assuming recovery followed a single exponential time course. Times longer than 20 min were not used to avoid error due to possible baseline drift. Each k off value was the average of greater than or equal to nine oocytes.
Extracellular recording of CAPs from rat and mouse sciatic nerves. Preparation of sciatic nerves and recordings from them were performed essentially as described previously (Fiedler et al. 2008; Wilson et al. 2011a) . Briefly, sciatic nerves were dissected from adult male Sprague-Dawley rats and Swiss Webster or C57/BL6 mice, desheathed, and used within ϳ2 h. A given nerve was placed in a multiwell Vaseline-gap chamber, made of Sylgard. Each well was 4 mm in diameter and ϳ4 mm deep, with ϳ1 mm wide partitions between adjacent wells. All wells contained mammalian Ringer's solution consisting of 140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1.1 mM MgCl 2 , and 5 mM HEPES, pH 7.4. The proximal end of the nerve was in well 1 and the distal end in either well 3 or 4. The portions of the nerve overlying the partitions were covered with Vaseline. The nerve was stimulated with wire electrodes in wells 1 and 2, and CAPs were recorded with a pair of wire electrodes in either wells 2 and 3 or 3 and 4, with the electrode in the lower-numbered well connected to the positive input of the preamplifier. A ground electrode was situated in well 2 or 3. All electrodes were platinum wires. Extracellular records were acquired with a differential capacitive-coupled preamplifier, band-pass filtered (1 Hz-1 kHz) and sampled at 4 kHz using in-house software written in LabVIEW. The amplitude of a 0.1-to 1-ms duration constant-voltage pulse was adjusted to provide a supramaximal stimulus that evoked both A-and C-CAPs, and the stimulus was applied once/minute. Normally, the nerve was exposed to toxin by replacing the solution in a middle well with toxin-containing Ringer's solution. In experiments with O §-GVIIJ SSC/G , the Ringer's solution also contained 0.1 mg/ml BSA to minimize nonspecific binding. [Separate experiments with oocytes showed that the presence of BSA did not affect the peptide's activity (not illustrated).] In the case of tests with ␦-PVIA, which inhibits channel inactivation, the toxin was applied to the last well, i.e., the well with the recording electrode that fed into the negative input of the preamplifier, as described previously (Bulaj et al. 2001) . Solutions in all wells were static and manually replaced every 10 -15 min with fresh solutions. To minimize evaporation, the atmosphere immediately above the wells was exposed to a gentle stream of water-saturated air.
Following tests of O §-GVIIJ SSC on sciatic nerves, the tested (i.e., "used") peptide was retrieved from the well and assayed for 1) functional activity on voltage-clamped oocytes expressing mNa V 1.6 (see above) and 2) structural integrity by HPLC (see below).
Whole-cell voltage-clamp recording of I Na from acutely dissociated DRG neurons from rat. DRG neurons of adult male Sprague-Dawley rats were dissociated and used as described previously (Zhang et al. 2013b) . Briefly, ganglia were excised and treated with collagenase, followed by trypsin. Cells were mechanically dissociated by trituration, washed, and suspended in Leibovitz L-15 medium, supplemented with 14 mM glucose, 1 mM CaCl 2, 10% FBS, and penicillin/ streptomycin. Dissociated neurons were kept in suspension at 4°C for up to 3 days (Blair and Bean 2002) . Voltage-clamp recordings were performed with a MultiClamp 700A amplifier (Axon Instruments, Union City, CA) using a bath with a total volume of 100 l, essentially as described previously (Zhang et al. 2013b ). The extracellular solution contained 140 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 0.1 mM CdCl 2 , and 20 mM HEPES, pH 7.3. Patch pipettes had resistances of Ͻ2 M⍀ and contained 140 mM CsF, 10 mM NaCl, 1 mM EGTA, and 10 HEPES, pH 7.3; series resistance compensation was Ͼ80%. After the achievement of whole-cell clamp conditions, recordings were not initiated until the holding current had settled, which required Ͼ10 min. The contribution of Na V 1.9, relative to that of Na V 1.8, to the TTX-resistant current of DRG neurons is minimized by such a settling period (Choi et al. 2006 ). The membrane potential was held at Ϫ80 mV, and I Na were elicited with a 50-ms step to 0 mV, applied every 20 s. Current signals were low-pass filtered at 3 kHz, digitized at a sampling frequency of 10 kHz, and leak subtracted by a P/6 protocol using in-house software written in LabVIEW.
Toxins were dissolved in extracellular solution and applied to the clamped neuron by simple bath exchange that involved manually applying, with a pipette, toxin solution (150 l) at one end of the boat-shaped, 100-l chamber, while simultaneously withdrawing solution at the other end of the chamber over a time span of Ͻ20 s. The patch electrode was used to lift the cell from the chamber bottom and position the cell near the upstream half of the chamber to ensure that the cell was fully exposed to the introduced toxin solution. Toxin exposures were conducted in a static bath to conserve toxin. The level of TTX-resistant I Na of each DRG cell was determined by perfusion with 1 M TTX following tests with O §-GVIIJ SSG , which does not block rNa V 1.8 expressed in oocytes (Gajewiak et al. 2014) .
Use of animals in this study followed protocols approved by the University of Utah's Institutional Animal Care and Use Committee that conform to the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
All electrophysiological experiments were conducted at room temperature (ϳ22°C).
HPLC of used O §-GVIIJ SSC . Qualitative and quantitative analyses of used O §-GVIIJ SSC (see above) were performed with an analytical C 18 Vydac reversed-phase HPLC column (218TP54, 250 mm ϫ 4.6 mm, 5 m particle size) at 23°C. Solvents consisted of 0.1% (v/v) trifluoroacetic acid in either water (solvent A) or 90% aqueous acetonitrile (solvent B). The sample was eluted with solvent A and a linear gradient of 15-45% solvent B. The optical absorbance of the eluent was monitored at 220 nm.
RESULTS

mNa V 1.6, expressed in oocytes, is blocked by -contoxins
BuIIIB and SxIIIA more potently than rNa V 1.6. In previous experiments, we tested -BuIIIB and -SxIIIA against mNa V 1.6 expressed in X. laevis oocytes without any Na V ␤-subunit coexpression, and they had similar IC 50 (1.8 and 0.57 M, respectively) (Wilson et al. 2011a ). All of the experiments described below that involved coexpression with Na V ␤-subunits used ␤-subunits from rat, because clones from mouse were unavailable to us. Thus we tested -BuIIIB and -SXIIIA against rNa V 1.6 and mNa V 1.6, coexpressed with rNa V ␤1, and observed that although both peptides had similar affinities for a given channel, each had a higher affinity for mNa V 1.6 than rNa V 1.6 ( Fig. 1) , where the higher affinity of -BuIIIB for mNa V 1.6 is a consequence of a larger k on and smaller k off (Table 1) . Values of k on for -SXIIIA were too large to be measured with our oocyte system; however, the k off of -SxIIIA for the rat channel is similar to that for the mouse channel ( Table 1 ), indicating that the higher affinity of -SxIIIA for mNa V 1.6 results from a larger k on for the mouse, over rat, channel.
The block by -SxIIIA of mNa V 1.6, coexpressed with various combinations of the four Na V ␤-isoforms, was examined (Table 2) . Coexpression with Na V ␤1 or -␤3 minimally affected affinity. In contrast, coexpression with Na V ␤2 or -␤4 increased the IC 50 Ͼ10-fold. This increase in IC 50 observed with unary coexpression of Na V ␤2 or -␤4 was largely "reversed" with binary coexpression of Na V ␤2 or -␤4 with Na V ␤1 or -␤3 (Table 2) .
O §-GVIIJ SSC and -GVIIJ SSG block mNa V 1.6, expressed in oocytes, except when Na V ␤2 or -␤4 is coexpressed. Two synthetic derivatives of the recently discovered O §-GVIIJ IC 50 values derived from these fits are presented in Table 1 . Fig. 1E . rNa V 1.6, rat ␣-subunit of voltage-gated sodium channels; Na V ␤1, ␤-subunit of voltage-gated sodium channels; r␤1, rat ␤1; mNa V 1.6, mouse Na V 1.6.
were tested, GVIIJ SSC and GVIIJ SSG , where the subscripts indicate that cysteine or glutathione, respectively, was disulfide bonded to Cys24 of the peptide (see MATERIALS AND METHODS). mNa V 1.6 expressed alone was readily blocked by O §-GVII-J SSC or O §-GVIIJ SSG (Fig. 2, A and J) . O §-GVIIJ SSC also readily blocked mNa V 1.6, coexpressed with either Na V ␤1 or -␤3 (Fig. 3, B and D) ; in contrast, coexpression with Na V ␤2 or -␤4, either alone or in binary combination with Na V ␤1 or -␤3, protected the channels against block by the peptide (Fig. 2,  E-I ). The kinetic constants of the block by O §-GVIIJ SSC are tabulated in Table 3 .
Block by -conotoxins of A-and C-CAPs in the mouse sciatic nerve. We previously observed that neither A-nor C-CAPs in the rat sciatic nerve are blocked by -SxIIIA or -BuIIIB (Wilson et al. 2011a ). However, our results above suggest that if Na V 1.6 were a major Na V 1-isoform of A-fibers in mouse sciatic nerve, then both peptides should be able to block mouse A-CAPs. This was indeed observed (Fig. 3 , F and G; Table 4) .
A-CAPs in the mouse sciatic nerve were also blocked by five other -contoxins (Fig. 3 , A-E, and Table 4 ) that were previously shown to block mNa V 1.6 expressed in oocytes (Wilson et al. 2011a) . Two of these, -SmIIIA and -KIIIA, not only blocked mouse sciatic nerve A-CAPs but also rapidly blocked C-CAPs (Fig. 3, A and B) , just as they do A-and C-CAPs of the rat sciatic nerve (Wilson et al. 2011a ). -SIIIA slowly blocked mouse C-CAPs (Fig. 3C) , whereas rat C-CAPs were resistant to -SIIIA (Wilson et al. 2011a) . Thus it is possible that mNa V 1.7 may be more susceptible than rNa V 1.7 to -SIIIA. Although -BuIIIB may block C-CAPs, it does so only poorly if at all (Fig. 3G and Table 4) .
At 10 M, all of the -conotoxins in Fig. 3 (and also listed in Table 4 ) blocked mouse A-CAPs essentially completely, except -SxIIIA (Fig. 1C) . To examine this further, a threefold-higher concentration of -SxIIIA (30 M) was tested; it blocked the A-CAP at least 95% (Fig. 3I) , consistent with a pharmacologically homogeneous population of channels underlying A-CAPs.
TTX (0.1 M) blocked 100% of the A-CAPs and ϳ80% of the C-CAPs (Table 4) , where the conduction velocity of the highly attenuated C-CAPs was decreased markedly (Fig. 3H) . The residual amplitude of C-CAPs that persists presumably reflects the presence of Na V 1.8 and/or -1.9, which are TTX resistant, in C-fibers. These TTX results essentially mirror those observed with A-and C-CAPs of the rat sciatic nerve (Wilson et al. 2011a) .
A-and C-CAPs in mouse and rat sciatic nerves are not blocked by O §-GVIIJ SSC or -GVIIJ SSG . Neither O §-GVII-J SSC nor O §-GVIIJ SSG was able to block A-and C-CAPs in mouse and rat sciatic nerves at 33 M (Fig. 4, A and B) , a concentration well beyond that necessary to block the majority of the I Na of mNa V 1.6, provided it wasn't coexpressed with Na V ␤2 or -␤4 (Fig. 2 and Table 3 ). In addition, inspection of Fig. 4 also shows that O §-GVIIJ SSC/G produced no increase in the latency of A-or C-CAP, indicating no decrease in the conduction velocity of action potentials in A-or C-fibers.
To examine whether the peptide was degraded or absorbed by the tissue to which it was exposed, the used toxin solution was retrieved and examined for structural integrity by subjecting it to HPLC analysis ( Fig. 4C) , as well as for functional activity against mNa V 1.6 expressed in oocytes, which was performed as follows. A sample of used GVIIJ SSC solution was diluted 10-fold with ND96 and assayed on an oocyte expressing mNa V 1.6. The k obs of I Na was 3.0 min Ϫ1 , which (after accounting for the 10-fold dilution) is that expected of a GVIIJ SSC concentration of 26 M, a value 21% lower than the starting 33 M. The slightly (20 -30%) lower-than-expected values obtained with the HPLC and oocyte assays can be explained by dilution due to siphoning of Ringer's solution from adjacent wells during retrieval of the contents from the toxin-containing well. Thus by both structural and functional assays, the used toxin proved to be intact and largely recoverable.
␦-PVIA affects A-CAPs of the mammalian sciatic nerve, like members of all other families of conotoxins that target VGSCs except O §-conotoxins. As mentioned previously, there are five families of conotoxins that target VGSCs. Until now, all families, except O §-and ␦-conotoxins, have been shown to affect A-CAPs of the mammalian sciatic nerve (see DISCUS-SION) . Earlier experiments with ␦-PVIA and -SVIE showed that these peptides prolonged the action potentials in peripheral nerves of frogs (Rana pipiens) (Bulaj et al. 2001; West et al. 2005) , and here, we examined whether ␦-PVIA could be shown also to act on the mammalian (specifically, rat) sciatic nerve. Indeed, 10 M ␦-PVIA greatly prolonged the A-CAP (Fig. 5) . The prolonged A-CAPs persisted longer than the latency of the C-CAPs and therefore, rendered accurate characterization of the latter problematical, so the effects of ␦-PVIA on C-CAPs remain to be determined. The effect of ␦-PVIA on A-CAPs was very robust and distinctive and closely resembled that seen with ␦-SVIE on A-CAPs of frog nerve [see Fig. 3B in Bulaj et al. (2001) ]. The profound potentiation and prolongation of the upward phase of A-CAPs induced by ␦-PVIA, illustrated in Fig. 5 , were observed in duplicate (two out of two) trials but never in traces of countless trials without the peptide [e.g., see traces in Fig. 4 , as well as Fig. 3 , of Wilson et al. (2011a) ]. This result supports the notion that peptide inaccessibility is an unlikely cause for the lack of activity of O §-GVIIJ SSC/G on the sciatic nerve, as recounted in DISCUSSION. O §-GVIIJ SSG blocks I Na of small, but not large, dissociated rat DRG neurons. The inability of O §-GVIIJ SSC/G to block CAPs raises the question of whether these peptides had any activity on endogenous VGSCs. To examine this issue, three small and three large dissociated rat DRG neurons were wholecell patch clamped as before (Zhang et al. 2013b ) and subjected to 10 M O §-GVIIJ SSG . The peptide blocked, albeit partially, TTX-sensitive I Na of all three small neurons; in contrast, all three large neurons were insensitive to the peptide (Fig. 6 ). Similar tests with O §-GVIIJ SSC remain to be performed.
DISCUSSION
In this report, we examined the effects primarily of two conotoxin families, -and O §-conotoxins, on VGSCs in Fig. 2 . O §-GVIIJ SSC (where subscript refers to cysteinylated) readily blocks mNa V 1.6, expressed alone or coexpressed with rNa V ␤1 or -␤3; however, coexpression with rNa V ␤2 or -␤4 protects mNa V 1.6 against block by O §-GVIIJ SSC . Oocytes were voltage clamped, as described in Fig. 1 . A-J: there are 10 pairs of panels. Top: representative time course of block before, during, and after exposure to GVIIJ SSC (A-I) or GVIIJ SSG (where subscript refers to glutathionylated; J), where the bar represents when peptide was present (thin black bars, 1 M; thick black bars, 33 M). Bottom: sample responses before (light traces) and during (dark traces) toxin application. First and last pair of panels represent mNa V 1.6 expressed alone (A and J), and the remaining 8 pairs of panels are labeled with the rNa V ␤-subunits that were coexpressed with mNa V 1.6 (B-I). GVIIJ SSC (1 M) readily blocked mNa V 1.6 expressed alone (A) or coexpressed with either Na V ␤1 (B) or Na V ␤3 (D); in contrast, 33 M GVIIJ failed to block whenever Na V ␤2 or -␤4 was coexpressed in either unary fashion (C and E) or binary combination with Na V ␤1 (F and G) or -␤3 (H and I). (Kinetic constants derived from replicate experiments are presented in Table 3 ). J: block of mNa V 1.6 (no Na V ␤-subunit coexpressed) by 10 M GVIIJ SSG ; time course (top; bar represents when peptide was present) and representative traces (bottom). Fig. 3 . Susceptibilities of large, myelinated A-fiber compound action potentials (A-CAPs) and small, unmyelinated C-fiber CAPs (C-CAPs) of the mouse sciatic nerve to each of 7 -conotoxins (10 M) or TTX (0.1 M). CAPs were evoked by electrical stimulation and recorded as described in MATERIALS AND METHODS. A-H: top 2 plots in each 4-plot panel show time course of normalized peak-to-peak amplitudes of A-CAPs (left) and C-CAPs (right), simultaneously recorded from the sciatic nerve, where the bars above each plot indicate when toxin was present; the x-axis scale (representing time in minutes), shown in left plots, applies to all top plots. Data points represent mean Ϯ SE values (n ϭ 3 sciatic nerves). Discontinuities in plots occurred when solutions in wells were refreshed (see MATERIALS AND METHODS) . Bottom 2 plots in each 4-plot panel show representative traces of A-CAPs (left) and C-CAPs (right). Traces obtained in control solution are gray, and in those, the presence of 10 M -conopeptide (A-G) or 0.1 M TTX (H) is black and either attenuated or largely unchanged compared with controls. A-and C-CAPs were captured in the same sweep but for clarity, are displayed with different time bases. Note stimulus artifact at the start of each A-CAP trace. The difference in latencies (i.e., time delays between stimulus and response) of A-and C-CAPs varied depending on length of nerve, and for illustration purposes, a fixed-space gap was placed between the end of a given A-CAP trace and the beginning of the following C-CAP trace. A quantitative summary of these results is presented in Table 4 . I: time course of block of mouse A-CAPs by 3 different concentrations of -SxIIIA, showing that a concentration of 30 M -SxIIIA blocks 95% of mouse A-CAPs (data for 10 M peptide were obtained from F). three preparations: 1) X. laevis oocytes exogenously expressing Na V 1.6, with or without various Na V ␤-isoforms; 2) A-and C-fibers of rodent sciatic nerves; and 3) soma of dissociated small and large neurons of rat DRG.
-Conotoxin sensitivities of rNa V 1.6 vs. mNa V 1.6. -BuIIIB and -SxIIIA blocked Na V 1.6 of rat and mouse with IC 50 values that differ by Ͼ50-fold (Fig. 1E and Table 1 ). This is in contrast to two other -conotoxins for which affinity data for both rat and mouse are available; namely, -SmIIIA and -PIIIA, each of whose dissociation constants for rNa V 1.6 vs. mNa V 1.6 differ by a factor of only 2.3 or less (Wilson et al. 2011a; Zhang et al. 2013a) . rNa V 1.6 and mNa V 1.6 differ in 10 residues, six of which are in the extracellular portions of the channel. Of these, three are in the pore loop regions: one in DII and two in DIII. The residue in question in DII is located near the N-terminal end of the S5-S6 (pore) loop: Asn907 in rNa V 1.6 and Ser907 in mNa V 1.6. The homologous residue in rNa V 1.4 is Ala728, and the activity of -conopeptide GIIIA, a potent blocker of rNa V 1.4 (Cruz et al. 1985) , has been tested extensively against mutants of rNa V 1.4 by several investigators, and a subset of those studies shows that mutations of Ala728 do influence the binding of -GIIIA and its congener, -GIIIB (Chahine et al. 1998; Li et al. 2003) . Furthermore, it was recently shown that the block of rNa V 1.4 by -SIIIA is reduced significantly by an A728N mutation (Leipold et al. 2011) . By extension, the single-residue difference in DII between rNa V 1.6 and mNa V 1.6 may be largely responsible for their different sensitivities to -BuIIIB and -SxIIIA.
SMIIIA
Modulation of the sensitivity of mNa V 1.6 to -SxIIIA by coexpression of rNa V ␤-subunits. Investigations of the pharmacological consequences of coexpression of Na V ␤-subunits have been limited, but several previous studies demonstrate that coexpression of Na V ␤-subunits can affect the affinity of agents targeted at the Na V 1-or ␣-subunit (Gajewiak et al. 2014; Tan et al. 2011; Wilson et al. 2011b; Zhang et al. 2013a ). Thus it is no surprise that the block of mNa V 1.6 by -SxIIIA was also modulated by coexpression of Na V ␤-subunits. mNa V 1.6, coexpressed without or with various rat ␤-subunits, had the following overall sequence of IC 50 values: no beta Ϸ ϩ␤1 Ϸ ϩ␤3 Ϸ 0.5 M Ͻ ϩ␤1ϩ␤4 Ϸ ϩ␤3ϩ␤4 Ϸ ϩ␤3ϩ (Table 2 ). This sequence of affinities, produced by unary and binary coexpression of the various Na V ␤-subunits, is also observed in the block of rNa V 1.7 by -SmIIIA (Zhang et al. 2013a) ; that is, unary coexpression of Na V ␤1 or -␤3 has minimal effects, and that of Na V ␤2 or -␤4 has the largest effects, whereas binary coexpression of Na V ␤1 or -␤3 with Na V ␤2 or -␤4 tempers the effects observed with unary coexpression of Na V ␤2 or -␤4.
Despite the congruity of results described immediately above, it should be noted that there are differences in the sequences of a given rNa V ␤-isoform and that from mNa V 1.6 -there is a two-residue difference for ␤1, one for ␤3, six for ␤2, and five for ␤4 -so the results from coexpression of an Na V 1-isoform from one rodent species with an Na V ␤-isoform from a another species should be viewed with caution.
Modulation of the sensitivity of mNa V 1.6 to O §-GVIIJ SSC by coexpression of rNa V ␤-subunits. The recently discovered O §-GVIIJ is the charter member of a new, fifth family of conotoxins that target VGSCs. Until now, it has been tested only on rat VGSCs expressed in oocytes, where it readily blocks rNa V 1.1, -1.2, -1.3, -1.4, -1.6, and -1.7 (Gajewiak et al. 2014) , all of which happen to be sensitive to TTX. It should be noted that the TTX sensitivity is largely dictated by an aromatic residue in site 1 near the ion-selectivity filter (Santarelli et al. 2007) , whereas the O §-GVIIJ sensitivity is dictated by a Cys residue in the newly described site 8 between S5 and SS5 (the latter is the proximal limb of the pore loop) of DII (Gajewiak et al. 2014) .
By and large, O §-GVIIJ SSC and O §-GVIIJ SSG behave similarly, both in previous (Gajewiak et al. 2014) and present experiments. A subtle difference is that the on rate of O §-GVIIJ SSC is apparently larger than that of O §-GVIIJ SSG , which is evident in Fig. 2 (compare pairs in Fig. 2A with Fig.  2J , keeping in mind the difference in peptide concentrations). This is also the case with rNa V 1.2 and -1.7, where the k on of O §-GVIIJ SSC is approximately threefold larger than that of O §-GVIIJ SSG (Gajewiak et al. 2014) . Cysteine is smaller than glutathione, and this may explain the difference in k on . A detailed examination of this issue is under way with derivatives of O §-GVIIJ, where the moiety disulfide bonded to Cys24 of 
NA ‡ NA ‡ NA ‡ *Values are mean Ϯ SD (n Ն 9 oocytes for k on values; n Ն 3 oocytes for k off values).
† K d , dissociation constant; determined from k off /k on . ‡NA values not available because no block was observed in n Ն 3 oocytes. Representative responses are illustrated in Fig. 2 . SSC, cysteinylated analog. † t 1/3 , time to block by 33.3%. Significantly different from no block; ¶ P Ͻ 0.05, §P Ͻ 0.001 (1-tail Student's t-test, assuming % block cannot be Ͻ0). ‡Expected block percentage of mNa V 1.6 with no Na V ␤-subunit coexpressed in X. laevis oocytes from Supplemental Table 5 of Wilson et al. (2011a) . A-CAPs, large, myelinated A-fiber compound action potentials; C-CAPs, small, unmyelinated C-fiber CAPs.
the peptide varies over a range of sizes and charges (unpublished observations).
A stellar feature of O §-GVIIJ SSC/G is that coexpression with Na V ␤2 or -␤4 renders otherwise-susceptible rNa V 1s resistant to the peptide (Gajewiak et al. 2014) . We now show that this modulation by coexpression of Na V ␤2 or -␤4 also applies to mNa V 1.6 (Fig. 2 and Table 3) . Furthermore, the protection of mNa V 1.6 against O §-GVIIJ SSC/G block by coexpression with Na V ␤2 or -␤4 persists in the face of binary coexpression with Na V ␤1 or -␤3; i.e., the effects of Na V ␤2 or -␤4 coexpression dominate those of Na V ␤1 or -␤3 (Table 3) . Similarly, dominance of the coexpression of Na V ␤2 and -␤4 over that of Na V ␤1 was observed with rNa V 1.2 (Gajewiak et al. 2014) . This is unlike the effects of Na V ␤2 or -␤4 coexpression on the block of mNa V 1.6 by -SxIIIA, which are attenuated by binary coexpression with Na V ␤1 or -␤3 (Table 2) . As mentioned in INTRODUCTION, Na V ␤2 and -␤4 are disulfide bonded to the ␣-subunit. The binding site of O §-GVIIJ on Na V 1, site 8, has a Cys residue with which we hypothesized the peptide can form a disulfide bond; furthermore, we speculated that Na V ␤2 and -␤4 may protect the channel against block by being disulfide bonded with the Cys at site 8 (Gajewiak et al. 2014) . Further investigation of this possibility is underway.
It should be emphasized that the modulatory effect of coexpression of ␣-with ␤-subunits does not necessarily mean that the modulation results from the subunits' physical association per se; for example, Na V ␤1 coexpression can affect the glycosylation of the ␣-subunit (Laedermann et al. 2013) . Thus in principle, the alteration in the pharmacology of a VGSC could result from the coexpression of the ␤-subunit altering the processing of the channel. , and in 10 M SmIIIA (dotted traces, where A-CAP was totally blocked, while C-CAP was dramatically slowed and attenuated). The shaded area at the start of the mouse A-CAP trace contains the stimulus artifact and can be ignored. Toward the end of a rat nerve trial, 33 M GVIIJ SSG was also applied, and still, no block of A-and C-CAPs was seen (not illustrated). C: the "used" GVIIJ SSC solution from a rat trial was retrieved at the end of the experiment and subjected to analysis by HPLC (see MATERIALS AND METHODS) . The elution profile consisted of a single peak with the same retention time as unused GVIIJ SSC (Gajewiak et al. 2014) , showing that the peptide remained intact, and integration under the peak indicated that ϳ0.8 nmol was applied to the column, a value 29% lower than the expected 1.1 nmol. A 220 , absorbance at 220 nm.
Effects of -BuIIIB, -SxIIIA, and five other -conotoxins on A-and C-CAPs of mouse sciatic nerve are consistent with Na V 1.6 and -1.7 mediating action potentials in A-and C-fibers, respectively . In previous experiments, we used a panel of -conotoxins and concluded that Na V 1.6 and -1.7 were the major Na V 1-isoforms responsible for the conduction of action potentials in A-and C-fibers, respectively, of rat sciatic nerve (Wilson et al. 2011a) . Results in Fig. 3 and Table 4 lead us to conclude the same for the mouse sciatic nerve. We do not have a clone of mNa V 1.7, so we assume that mNa V 1.7 behaves similar to rNa V 1.7 toward the tested -conotoxins, with the possible exception of -SIIIA, which we speculated in RESULTS may block rNa V 1.7 better than rNa V 1.7. This issue can be resolved when an mNa V 1.7 clone becomes available.
The safety factor for action potential conduction can be defined as the current generated during an action potential divided by the threshold current necessary for the action potential to be propagated (Fern and Harrison 1993) or for our purposes, the density of sodium channels available for activation during an action potential divided by the minimum density of channels necessary for action potential conduction. In view of the safety factor, normally, a disproportionate fraction of sodium channels must be blocked before the action potential is blocked. For example, the IC 50 values of -SxIIIA in blocking rNa V 1.6ϩ␤1 and mNa V 1.6ϩ␤1 are 20 and 0.5 M, respectively (Table 1) . Given these IC 50 values, the Langmuir equation (see Table 2 ) predicts that 10 M SxIIIA would block 95% and 33% of the mouse and rat channels, respectively. On the other hand, our experiments show that 10 M -SxIIIA blocked ϳ70% of the A-CAPs in mouse (Table 4) and essentially 0% of those in rat [see Table 3 of Wilson et al. (2011a) ]. We do not know the safety factor for the conduction of A-CAPs in our experiments; however, the predicted block of Na V 1.6-containing VGSCs vs. the observed block of A-CAPs by 10 M SxIIIA can be qualitatively reconciled if we assume that the safety factor is approximately two for both mouse and rat nerves; that is, Ͼ50% of the channels must be blocked for A-CAPs to fail. The disparity in the block of channels vs. action potentials would be larger, the larger the safety factor. This analysis requires several assumptions and does not rule out the possible contribution of minor Na V 1-isoforms to A-CAPs.
Inability of O §-GVIIJ SSC/G to block A-and C-CAPs in rat and mouse sciatic nerves suggests that channels expressed in
A-and C-fibers are associated with Na V ␤2 or -␤4. GVIIJ SSC and GVIIJ SSG blocked neither A-nor C-CAPs in rat and mouse sciatic nerves (Fig. 4) . In principle, there are four relatively simple alternative reasons why no block was observed with O §-GVIIJ SSC/G ; namely, the peptide is 1) physically unable to reach to the axon surface where VGSCs reside; 2) absorbed by the tissue preparation; 3) rapidly degraded; or 4) unable to block endogenously expressed VGSCs. To address the first possibility, at the end of a trial with each of a mouse and rat sciatic nerve, the nerve was exposed to 10 M -SmIIIA, which readily blocked both A-and C-CAPs (Fig. 4) , as was invariably observed in multiple experiments with sciatic nerves of both mouse (Fig. 3A and Table 4 ) and rat (Wilson et al. 2011a ). In addition to -SmIIIA, many other -conotoxins are able to block A-and/or C-CAPs in sciatic nerves of mouse ( Fig. 3 and Table 4 ) and rat (Wilson et al. 2011a) . Furthermore, aside from O §-GVIIJ SSC/G , action potentials in A-and/or C-fibers of the mammalian sciatic nerve are susceptible to members of all other families of conotoxins that target VGSCs, i.e., O-conopeptides (Bulaj et al. 2006) , -conopeptides (Fiedler et al. 2008) , and ␦-conopeptides (Fig. 5) . It should be noted that O-and ␦-conopeptides are more hydrophobic than O §-GVIIJ, whereas -conotoxins are larger than O §-GVIIJ. Thus our overall results suggest that a peptide-accessibility issue is unlikely with O §-GVIIJ SSC/G .
To address the second and third possibilities, after one of the trials in Fig. 3 , the used O §-GVIIJ SSC was recovered and observed to be structurally intact (Fig. 4C ) and functionally active (see RESULTS regarding Fig. 4) , which shows that O §-GVIIJ SSC was not appreciably absorbed or degraded during exposure to tissue.
To address the fourth possibility, we examined dissociated rat DRG neurons. O §-GVIIJ SSG partially blocked the I Na of small neurons, whereas the I Na of large neurons were spared (Fig. 6 ). This showed that at least some endogenous channels are susceptible to the peptide. A-and C-CAPs arise from fastand slow-conducting axons of neurons with, respectively, large and small cell somas in DRG (Harper and Lawson 1985) ; thus the resistance of the I Na of large cells to O §-GVIIJ SSG (Fig.  6) is consistent with the resistance of A-CAPs to the peptide
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Time ( ( Fig. 4) . A-Fibers are myelinated, so one would predict that VGSCs at nodes of Ranvier are associated with Na V ␤2 or -␤4. Furthermore, since DRG neurons with small soma diameters give rise to unmyelinated C-fibers responsible for C-CAPs, the resistance of C-CAPs to O §-GVIIJ SSC/G suggests that in contrast to VGSCs expressed on the soma of small neurons, VGSCs in the bulk of its axons are associated with Na V ␤2 or -␤4. The Na V ␤4-subunit is involved in resurgent currents (Bant and Raman 2010; Lewis and Raman 2014 ) that were originally identified in cerebellar Purkinje neurons, which express Na V 1.6 . Specifically, the intracellular tail of Na V ␤4 has been implicated as the component responsible for resurgent currents (Grieco et al. 2005) . Resurgent currents have also been observed in large DRG neurons expressing Na V 1.6 (Cummins et al. 2005 ). Thus our results would predict that channels exhibiting resurgent currents would be resistant to O §-GVIIJ SSC/G ; conversely, channels that do not exhibit resurgent currents and yet are resistant to O §-GVIIJ SSC/G may be associated with Na V ␤2. However, this assessment may be too simplistic in light of a recent report that a critical regulator of a resurgent current in cerebellar Purkinje neurons is intracellular FGF14 (Yan et al. 2014) .
The block by saturating concentrations of O §-GVIIJ SSC/G of various Na V 1s expressed in oocytes is not 100%; i.e., there remains a "residual current" (Gajewiak et al. 2014) . It is presently unknown how much of the incomplete block of the TTX-sensitive I Na of small neurons by O §-GVIIJ SSG (Fig. 6 ) is due to channel heterogeneity and how much to partial efficacy. Heterogeneity in the oxidation state of the Cys residues of the channel can contribute to incomplete block, insofar as DTT treatment of Na V 1s expressed in oocytes reduces the residual current (Gajewiak et al. 2014) ; thus it would be interesting to see whether DTT treatment of DRG neurons or sciatic nerve can likewise increase the efficacy of block of endogenous channels by O §-GVIIJ SSC/G . In this regard, it might be noted that we have not determined the safety factor for the propagation of A-and C-CAPs under our experimental conditions; however, as mentioned in RESULTS in describing Fig. 4 , O §-GVIIJ SSC/G produced no decrease in action potential conduction velocity; in other words, no evidence for partial block was detected.
Thus our current working hypothesis is that coexpression of Na V ␤2 and/or Na V ␤4 protects Na V 1s in both A-and C-fibers against block by O §-GVIIJ. This proposition is concordant with other observations; that is, immunohistochemistry, PCR, and in situ hybridization indicate that all four Na V ␤-subunit isoforms are expressed in DRG neurons (Coward et al. 2001; Takahashi et al. 2003; Yu et al. 2003) with Na V ␤2 expressed in both large and small DRG neurons (Ho et al. 2012) . Furthermore, the majority of the nodes of Ranvier in rat peripheral nerve is labeled by antibody against Na V ␤4 (Buffington and Rasband 2013), and in view of our results, the nodes not expressing Na V ␤4 presumably have VGSCs associated with Na V ␤2 instead.
If we accept that Na V ␤2 or -␤4 is associated with Na V 1.6 in A-fibers, then it seems reasonable to suggest that Na V ␤1 or -␤3 is also part of the VGSC complex in view of the influence that binary coexpression of Na V ␤-subunits has on percentage block of mNa V 1.6 by -SxIIIA. Block by 30 M -SxIIIA of mNa V 1.6 coexpressed with ␤4 is expected to be only 73%, whereas 97% block is expected if the channel were coexpressed with ␤1ϩ␤4 or ␤3ϩ␤4 (Table 2 ). -SxIIIA, at concentrations of 30 M, blocked mouse A-CAPs by ϳ95% (Fig.  3I) . In view of the safety factor for conduction of action potentials, a disproportionate fraction of sodium channels must be blocked relative to the reduction of the CAP; thus for -SxIIIA to be as potent as it is in blocking A-CAPs in mouse sciatic, Na V 1.6 in A-fibers is likely to be associated with ␤1 or ␤3 in addition to ␤2 or ␤4.
We assume here that the -conotoxin susceptibilities of VGSCs exogenously expressed in oocytes can be applied directly to channels endogenously expressed in neurons and axons, as we have done previously (Wilson et al. 2011a; Zhang et al. 2013b ). -Conotoxins bind to site 1 near the selectivity Acutely dissociated neurons were whole-cell patch clamped, as described in MATERIALS AND METHODS. The holding potential was Ϫ80 mV, and I Na was induced by a 50-ms step to 0 mV, applied every 20 s. A: percentage block by GVIIJ SSG of TTX-sensitive I Na of 3 small and 3 large neurons; neuron sizes were determined quantitatively by membrane capacitance (see x-axis) and qualitatively by visual inspection. B: 4-plot panel showing representative traces of small (top left) and large (top right) neurons before (light traces) and during (dark traces) exposure to GVIIJ SSG . Peak I Na of these neurons plotted as a function of time (bottom); bars represent when neuron was exposed to GVIIJ SSG . Illustrated are results of the 12.6-pF small neuron (bottom left) and 45.8-pF large neuron (bottom right). The I Na of all neurons was blocked essentially completely by 0.1 M TTX, except for the 11.1-pF neuron, which was blocked by 60% (not illustrated).
filter and block the channel by interfering with Na ϩ conduction (Cestèle and Catterall 2000; Zhang et al. 2009 Zhang et al. , 2010a . On the other hand, O-GVIIJ SSC/SSG binds to site 8 between S5 and SS5 of the pore loop of DII, although its mechanism of block remains to be established (Gajewiak et al. 2014) . Thusand O §-conotoxins (both of which are relatively hydrophilic) bind to extracellular aspects of the channel and may therefore be minimally influenced by the lipid composition of surrounding the plasma membrane. In this regard, it might be noted that the Na V 1-isoform selectivity of O-GVIIJ SSG is similar whether the channels are expressed in X. laevis oocytes or mammalian cell lines (human embryonic kidney 293 and Chinese hamster ovary cells) (Gajewiak et al. 2014) .
Although it is most parsimonious to assume that coexpression of Na V ␤2 or -␤4 is responsible for protecting the endogenous VGSCs from block by O §-GVIIJ SSC/G , we cannot rule out that some other factor confers resistance of A-and C-CAPs to O §-GVIIJ SSC/G ; e.g., the efficacy of the peptide in blocking endogenously expressed VGSCs that are not coexpressed with Na V ␤2 or -␤4 may be sufficiently small and/or the safety factor for propagation of action potentials sufficiently large that the inhibition or slowing down of action potentials by O §-GVIIJ SSC/G is not observable in CAPs. More sensitive means to monitor the effects of toxins on action potentials in the sciatic nerve are under investigation, such as experiments under reduced concentrations of extracellular Na ϩ or in the presence of low concentrations of TTX (Colquhoun and Ritchie 1972; Fern and Harrison 1993) , as well as experiments to see whether O §-GVIIJ SSC/G alters the stimulus strength required to generate action potentials following placement of the toxin in the well containing the depolarizing stimulus electrode.
Thus far, we have examined only VGSCs on the cell bodies and bulk of the axons in the peripheral nervous system, and it would be interesting to examine whether -and O §-conotoxins can be used to assess the likely molecular composition of VGSCs at nerve terminals, as well as at various locations of central nervous system neurons.
